Global Pharmaceutical Projects Announced

Vaxxas Unveils Manufacturing Facility in Queensland, Australia

Vaxxas unveils worldclass facility for needlefree vaccine patch production and commercial products in Queensland, Australia

Biovian Unveils Plan for US$54 million (€50 million) Manufacturing Facility Investment in Turku, Finland

Biovian has unveiled plans to make an investment of US$54 million 50 million in expanding its manufacturing facility in Turku, Finland

Merck Invests US$27 million (€23 million) to Expand Cell Culture Media Production in USA

Merck invests US$27 million 23 million to expand Cell Culture Media Manufacturing facility in Kansas, USA

Sandoz Invests US$90 million to Open Biosimilar Technical Development Centre in Slovenia, Europe

The new stateoftheart endtoend drug product development centre represents a significant investment in biopharma technical development capabilities

Agilent Plans to Invest US$22M to Expand its Newport Plant

The expansion plans involve several components such as the addition of new reactors, the decommissioning of an old reactor, and the establishment of new production laboratories

Boehringer Ingelheim Invests US$314 million (EUR 285 million) to Construct New Chemical Innovation Plant

Boehringer Ingelheim with an investment of US$314 million EUR 285 million plans to build a new Chemical Innovation Plant in Ingelheim, Germany

The University of Kansas Cancer Centre Opens New Cancer Research and Care Facility

The University of Kansas Cancer Centre received US$100 million as a gift from The Sunderland Foundation to construct a stateoftheart cancer centre The facility will be located in USA

Novo Nordisk Invests US$2.3 billion (DKK 15.9 billion) to Expand Manufacturing Facilities

Novo Nordisk plans for the expansion of current Active Pharmaceutical Ingredient API production facility in Denmark This expansion supports the development of future portfolio of treatments for serious chronic diseases